Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2020.9(7): 2581-2587
DOI: https://doi.org/10.20546/ijcmas.2020.907.304


Relationship between Malignancy Types and Toxoplasmosis Incidence in Malignancy Patients with Chemotherapy at Dr. M. Djamil Hospital
Selfi Renita Rusjdi1*, Emilia Sasqia Puteri2 and Almurdi3
1Parasitology Laboratory, Faculty of Medicine, Andalas University, Padang 25138, Indonesia
2Faculty of Medicine, Andalas University, Padang 25138, Indonesia
*Corresponding author
Abstract:

Toxoplasma gondii is a protozoan that causes toxoplasmosis. Immunological status is an important factor in the course of the Toxoplasma gondii parasitic infection. This disease is often the cause of opportunistic infections that can be life-threatening in immunocompromised individuals. In immunocompromised malignancies, the risk of infection is higher than in immunocompetent individuals. The risk of infection increases when malignancy patients with chemotherapy treatment which makes the patient's immune status decrease.To determine the relationship of the type of malignancy with the incidence of toxoplasmosis in malignancy patients with chemotherapy at RSUP Dr. M. Djamil Padang.This study was an observational analytic study with a cross-sectional design by using consecutive techniques. The research started from November2019 until January 2020 in the Chemotherapy Unit and Clinical Pathology Laboratory Dr. M. Djamil Padang with a total sample of fifty-four people. The research instrument used was the Enzyme-Linked Immunosorbent Assay (ELISA) test for IgG and IgM antibodies in the blood serum of toxoplasmosis patients.The incidence of toxoplasmosis in malignancy patients with chemotherapy at RSUP Dr. M. Djamil Padang as much as 74.1 percent. According to the division of types of malignancy, toxoplasmosis was found in hematological malignancies as much as 86.7 percent and in solid malignancies as much as 69.2 percent. The significance value obtained was 0.302.The type of malignancy was not significantly related to the incidence of toxoplasmosis in malignancy patients with chemotherapy because it did not meet the p-value <0.05.


Keywords: Toxoplasmosis, Malignancy types
Download this article as Download

How to cite this article:

Selfi Renita Rusjdi, Emilia Sasqia Puteri and Almurdi. 2020. Relationship between Malignancy Types and Toxoplasmosis Incidence in Malignancy Patients with Chemotherapy at Dr. M. Djamil Hospital.Int.J.Curr.Microbiol.App.Sci. 9(7): 2581-2587. doi: https://doi.org/10.20546/ijcmas.2020.907.304